ATIVAN

LOE Approaching

lorazepam

NDAINJECTIONINJECTABLE
Approved
Jul 1980
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
5

Mechanism of Action

CLINICAL PHARMACOLOGY Lorazepam interacts with the γ-aminobutyric acid (GABA)-benzodiazepine receptor complex, which is widespread in the brain of humans as well as other species. This interaction is presumed to be responsible for lorazepam's mechanism of action. Lorazepam exhibits relatively high…

Pharmacologic Class:

Benzodiazepine

Clinical Trials (5)

NCT01994668Phase 1Completed

Phase 1 Study to Characterize the Safety and Pharmacokinetics of Single Intravenous Dose of Lorazepam in Healthy Japanese Adult Subjects

Started Jan 2014
8 enrolled
Healthy
NCT01275144Phase 1Completed

A Study of the Effect of LY2216684 on Lorazepam

Started Dec 2010
28 enrolled
Major Depressive Disorder
NCT00465244Phase 2/3Withdrawn

Seizure Therapy With Intravenous Levetiracetam and Lorazepam

Started Jan 2008
0
Seizures
NCT00546624Phase 2Completed

GEM 1.5 mg b.i.d. to 4.5 mg b.i.d. Versus Lorazepam in GAD (0777-026)

Started Nov 2002
38 enrolled
Anxiety Disorder
NCT00249171Phase 4Completed

A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients

Started Jun 2001
226 enrolled
SchizophreniaPsychotic DisordersEmergency Treatment